Maryse Wiewel
Product Owner
/
MD PhD
Maryse brings deep clinical and scientific expertise to the product team. As Product Owner, she ensures PERISCOPE meets the needs of healthcare professionals in daily practice.
She holds both an MD and a PhD from the University of Amsterdam. Her doctoral research focused on molecular diagnosis and risk stratification in sepsis, studying host response and outcomes in critically ill patients. She subsequently trained as a Resident in Clinical Microbiology at Amsterdam UMC and OLVG, giving her firsthand experience with infectious disease management in hospital settings.
Before joining Healthplus.ai, she worked as a Postdoctoral Researcher and Programme Manager at Leiden University Medical Center.
Publications
Wiewel M, et al. Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis. Intensive Care Med, 2016.
van Vught, et al. Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the ICU After Admission for Sepsis. JAMA, 2016.
Herter, et al. Impact of a Machine Learning-Based Decision Support System for Urinary Tract Infections. JMIR Med Inform, 2022.
Education
MD, University of Amsterdam
PhD, Amsterdam UMC
Expertise
Human-centered design, user adoption, product management, implementation management, IEC 62366, data-analysis, infectious disease, sepsis, microbiology, population health management
